| 田群1 左维泽1 曹玉文2.慢性乙型肝炎抗病毒治疗研究进展[J].,2011,11(21):4187-4190 |
| 慢性乙型肝炎抗病毒治疗研究进展 |
| Update on the Anti-Viral Treatment of Chronic Hepatitis B |
| |
| DOI： |
| 中文关键词: 慢性乙型肝炎，抗病毒治疗，干扰素，核苷类药物 |
| 英文关键词: Chronic hepatitis B Antiviral therapy Interferon-α Nucleoside and nucleotide analogues |
| 基金项目: |
|
| 摘要点击次数: 647 |
| 全文下载次数: 956 |
| 中文摘要: |
| 乙肝病毒的慢性感染是肝纤维化、肝细胞癌的重要病因，积极有效地抗病毒治疗，可显著改善HBV 感染者的生活质量。干
扰素、核苷(酸)类药物的抗乙肝病毒疗效已得到全球公认，本文就上述两类药物的研究进展进行综述。 |
| 英文摘要: |
| The chronic HBV infection is the main factor of the complications of cirrhosis and hepatocellular carcinoma. All
patients who are positive for hepatitis B virus (HBV) DNA should be considered for antiviral treatment. It will improve their life. Interfron-
α and nucleoside and nucleotide analogues constitute the most potent of the antiviral therapy. The article reviewed the latest
advancement of Hepatitis B antiviral therapy. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
